Metformin Based Dual-Combination Therapies in Drug Naïve Type 2 Diabetic Patients
Dong-Lim Kim (Kim DL)
Diabetes Metab J. 2013;37(6):429-432.   Published online 2013 Dec 12     DOI: https://doi.org/10.4093/dmj.2013.37.6.429
Citations to this article as recorded by Crossref logo
Association between Metformin Use and Risk of Lactic Acidosis or Elevated Lactate Concentration in Type 2 Diabetes
Eun Young Lee, Sena Hwang, Yong-ho Lee, Seo Hee Lee, Young Mi Lee, Hua Pyong Kang, Eugene Han, Woonhyoung Lee, Byung-Wan Lee, Eun Seok Kang, Bong Soo Cha, Hyun Chul Lee
Yonsei Medical Journal.2017; 58(2): 312.     CrossRef
Initial Combination Therapy With Canagliflozin Plus Metformin Versus Each Component as Monotherapy for Drug-Naïve Type 2 Diabetes
Julio Rosenstock, Leonard Chuck, Manuel González-Ortiz, Kate Merton, Jagriti Craig, George Capuano, Rong Qiu
Diabetes Care.2016; 39(3): 353.     CrossRef
Cardioprotective effect of concomitant administration of trigonelline and sitagliptin on cardiac biomarkers, lipid levels, electrocardiographic and heamodynamic modulation on cardiomyopathy in diabetic Wistar rats
Hemant V. Kamble, Subhash L. Bodhankar
Biomedicine & Aging Pathology.2014; 4(4): 335.     CrossRef